🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Enhanced mucosal B- and T-cell responses against SARS-CoV-2 after heterologous intramuscular mRNA prime/intranasal protein boost vaccination with a combination adjuvant

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.03.28.587260Source: DataRank Database

Enhanced mucosal B- and T-cell responses against SARS-CoV-2 after heterologous intramuscular mRNA prime/intranasal protein boost vaccination with a combination adjuvant is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2024). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)OA: greenTopics (14)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Matthew Wiest,Dilara Karadağ ORCID,Prajakta Warang ORCID,Jessica J. O’Konek ORCID,Lauren A. Chang ORCID

Live enrichment

PubMed:38586014 OpenAlex:https://openalex.org/W4393344577

NIAID NIH HHS

Grant: R01 AI160706

NIDDK NIH HHS

Grant: R01 DK130425

NIAID NIH HHS

Grant: R21 AI176069

green

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2024/03/29/2024.03.28.587260.full.pdf

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2024/03/29/2024.03.28.587260.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2024.03.28.587260

repositoryhttps://doi.org/10.1101/2024.03.28.587260

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38586014

Fields of Study

SARS-CoV-2 and COVID-19 ResearchImmunotherapy and Immune ResponsesImmune Response and Inflammation

Keywords

VaccinationAdjuvantImmunologyImmune systemImmunityHeterologousMedicineAntigenAntibodyVirologyBiology

Sustainable Development Goals

SDG 0: Good health and well-being